Down syndrome in Israel
The incidence of Down syndrome was studied in Jerusalem for the years 1964-1970 showing an overall incidence rate of 2.43 per 1,000 live births. A National Down Syndrome Register was established in 1978 and data on annual incidence and mortality rates from 1979-1997 is presented. The incidence in 1997 was 1.0 per 1,000 live births, but 2.32 per 1,000, when live births and terminated pregnancies are summed. Infant mortality has generally decreased in the past 20 years in Israel, and a decrease in infant mortality in Down syndrome has also been noted. This is due to better medical treatment and increased parental involvement in the care for infants with Down syndrome.
Merrick, J. (2001) Down syndrome in Israel. Down Syndrome Research and Practice, 6(3), 128-130. doi:10.3104/reports.104
There has been a decline in infant mortality in Israel over the last 25 years. In 1997 the infant mortality rate for Jews was 4.9 per 1,000 live births, whereas for Arabs it was 9.3 resulting in a total rate of 6.2 (Ifrah, 1999).
This decline affects Jews as well as Arabs, with an especially marked decline in mortality due to infectious causes.
Congenital malformation continues to be the commonest cause of infant mortality although there has been a 61% decrease among Jews (and 38% decrease among Arabs) in mortality from this cause since 1970. Contributing causes for the difference between Jews and Arabs could be due to the higher extent of consanguineous marriage in the Arab population and a lower utilisation of prenatal screening.
Screening tests for carriers of the Tay-Sachs gene started in 1974, and in 1978 a national programme for the prevention of births defects was implemented by the Ministry of Health. Since 1979 data has been collected and analyzed on the births of infants with Down syndrome. The Down Syndrome National Register receives information from routine notifications from delivery rooms, cytogenetic laboratories in all hospitals and annual reports from hospital nurseries.
In 1978 free amniocentesis was offered to women over the age of 37 years, but since 1993 the age limit has been reduced to 35 years. The use of amniocentesis was 61% in pregnant Jewish women (over 35 years) in 1997 and 14% in younger women with a total 22.2% of all pregnant Jewish women. For Arab women the total utilisation was 4.2% (Ifrah, 1999). The use of amniocentesis in the target group of women over 35 years is higher than in other countries (England, the United States, Holland, Australia), where Steele and Stratford (1995) found no more than 50% utilization.
In 1990, 53% of the cases of Down syndrome among Jewish women were detected and terminated during pregnancy, whereas in 1997 this percentage had increased to 61.2%. In the Arab population 8% of pregnancies with Down syndrome were terminated in 1991, whereas in 1997 that figure had increased to 35.7% (Ifrah, 1999).
In 1997, there were 86,140 births among Jewish women and 38,338 amongst Arab women with the number of amniocenteses performed being 19,135 and 1,607 for Jewish and Arab women respectively. The total number of cases of Down syndrome diagnosed antenatally was 219 cases among Jewish women and 70 among Arab women. There were 85 live births among Jewish women and 45 live births among Arab women and 134 terminations among Jewish women and 25 terminations among Arab women during this period (Ifrah, 1999).
Trends in the incidence of Down syndrome
A prospective study from Jerusalem (Harlap, 1973) followed about 42,000 deliveries and found 103 infants with Down syndrome between the years 1964-1970. The incidence rates according to maternal age can be seen in Table1. The overall incidence rate for the period was 2.43 per 1,000 births with a tendency to increasing incidence with increase in maternal age. This rate is higher than some other countries during the same period, e.g. Australia (1.19), England (1.39) and the United States (1.44) (Steele, 1996).
|Maternal age bands in years|
The Ministry of Health in Israel started a National Program for Detection and Prevention of Birth Defects in 1974 and has collected data on Down syndrome since 1979. The number of live births and the incidence rate for Jews and non-Jews is shown in Table 2 (Klein et al., 1998). The total or true incidence rate for Down syndrome in 1997, including both live births and terminated pregnancies, for Jews and non-Jews was 2.32 per 1,000. This rate is not appreciably different from the rate found for the years 1964-1970 (Harlap, 1973), namely 2.43.
|Year||Total number of live births with Down syndrome||Rate per 1,000 live births for Jews||Rate per1,000 live births for non-Jews|
Trends in mortality
About 85% of deaths due to congenital malformations occur during the first year and a further 10% during the second to fourth years of the child's life. In 1995 the mortality rates in the 0-4 age group were 39.7 per 100,000 for Jewish males, 27.4 for Jewish females and, 89.2 for males and 80.9 for females in the Arab population. Mortality due to congenital malformations declined in the years 1970-1995 by 70% for Jewish males, 76% for Jewish females and 47 % for Arab males and 46 % for Arab females (Ifrah, 1999).
|Year||Number of deaths||Percentage of total|
These figures demonstrate a clear decrease in mortality since 1979. This decrease is caused by several factors. Firstly, because of technical developments in medicine, such as improved surgical techniques for cardiac and gastrointestinal malformations. Secondly, earlier and more effective medical treatment of infections and thirdly, a change in attitude both by parents, and also by medical and nursing staff in hospitals towards a much more positive attitude towards children born with Down syndrome (Sadetzki et al., 1999a, Sadetzki et al., 1999b).
|Year||Number of deaths||Percentage of total|
The total incidence of Down syndrome during the years 1964 through 1970 was found to be 2.43 per 1,000 live births. Data from the National Down Syndrome Register for the years 1979 through 1997 showed a decline in the incidence, but when live births and terminated pregnancies were summed the true incidence rate in 1997 was 2.32. Mortality rates have shown a clear decline since 1979 due to medical advances, but also due to a much more positive public attitude towards persons with Down syndrome in Israeli society.
Professor Joav Merrick, MD, DMSc, Medical Director, Division for the Mentally Retarded, BOX 1260, IL-91012 Jerusalem, Israel • E-mail email@example.com
- Harlap, S. (1973). Down syndrome in West Jerusalem. American Journal of Epidemiology, 97, 225-232.
- Ifrah, A. (Ed.) (1999). Health Status in Israel 1999. Tel Hashomer: Israel Center for Disease Control.
- Klein, H., Aburbeh, M., Bentolila, M., Shtein, N., Gordon, S. & Haklai, Z. (1998). Health in Israel. Selected Data. Jerusalem: Ministry of Health.
- Sadetzki, S., Chetrit, A., Akstein, E., Luxenburg, O., Keinan, L., Litvak, I. & Modan, B. (1999a). Risk factors for infant mortality in Down syndrome. A nationwide study. (unpublished data).
- Sadetzki, S., Chetrit, A., Keinan, L., Luxenburg, O. & Modan, B. (1999b). Disposition of infants with Down syndrome. (unpublished data).
- Steele, J. & Stratford, B. (1995). The United Kingdom population with Down syndrome: Present and future projections. American Journal on Mental Retardation, 99 (6), 664-682.
- Steele, J. (1996). Epidemiology: Incidence, prevalence and size of the Down's syndrome population. In B. Stratford and P. Gunn (eds), New Approaches to Down syndrome. London: Cassell. pp.45-72.